The Identification of Quality Risk Factors for Non-biological Complex Drugs and Epilepsy Drugs Using Statistical Analysis of Formulation-Based Recalls in the USA
Crossref DOI link: https://doi.org/10.1208/s12249-021-02165-w
Published Online: 2021-12-13
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kerstiens, Emily A.
Byrn, Stephen R.
Clase, Kari L. https://orcid.org/0000-0003-2749-6440
Text and Data Mining valid from 2021-12-13
Version of Record valid from 2021-12-13
Article History
Received: 30 March 2021
Accepted: 18 October 2021
First Online: 13 December 2021
Declarations
:
: The authors declare no competing interests.